Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Assets (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Other Non-Current Assets of $35989.7 for Q2 2025, up 12.07% on a QoQ basis from $32112.4 in Q2 2024, and up 12.07% year-over-year from $32112.4 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Assets (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Other Non-Current Assets history runs 2 years deep, the most recent figure standing at $35989.7 for Q2 2025.
- Quarterly Other Non-Current Assets rose 12.07% year-over-year to $35989.7 in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $35989.7 (up 12.07% YoY) and the FY2025 annual result came in at $36851.0, up 14.76% from the prior year.
- Other Non-Current Assets was $35989.7 for Q2 2025 at Phaos Technology Holdings (Cayman), up from $32112.4 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $35989.7 in Q2 2025 and bottomed at $32112.4 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 738.90 Mn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 2.25 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 285.90 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 164.00 Mn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 828.89 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 6.44 Mn | 6.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 35,989.75 |
| Apr 30, 2024 | 32,112.36 |